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Skip the compression stockings 
following DVT 
Although commonly used, compression stockings do not 
effectively prevent post-thrombotic syndrome.
PRACTICE CHANGER
Do not recommend elastic compression 
stockings (ECS) to decrease the incidence of 
post-thrombotic syndrome (PTS) after deep 
vein thrombosis (DVT).1
StRENGtH oF RECoMMENDAtioN
B: Based on a large, randomized controlled 
trial
Kahn SR, Shapiro S, Wells PS, et al; SOX trial investigators. Compres-
sion stockings to prevent post-thrombotic syndrome: a randomised 
placebo-controlled trial. Lancet. 2014;383:880-888. 
ILLUSTRATIVE CASE
a 56-year-old man comes to your clinic 3 days 
after receiving a diagnosis of lower extrem-
ity deep vein thrombosis (DVT). he was pre-
scribed warfarin, 5 mg/d, with enoxaparin 
bridging, 120 mg/d. he has read about post-
thrombotic syndrome (PTS) online and is very 
concerned about this possible side effect. he is 
asking about using elastic compression stock-
ings (ecS). What should you tell him?
PTS can be a frustrating, debilitating condition. Its clinical features range from minor limb swelling to severe 
edema and pain, irreversible skin changes, 
and leg ulcerations.2 It occurs in 25% to 50% 
of patients after DVT.3 Because current PTS 
treatments are not very effective, prevention 
is essential 4,5
Patients are frequently encouraged to 
wear ECS after DVT to reduce the incidence 
of PTS by reducing venous hypertension 
and reflux. These stockings are expensive 
and uncomfortable. Prior studies suggested 
that using ECS can cut the incidence of PTS 
in half.6,7 However, these were small, single-
center studies, and they were not placebo-
controlled.6,7
STUDY SUMMARY
RCt sets aside 
a common practice 
Kahn et al1 conducted a randomized, placebo-
controlled trial of active vs placebo ECS in pa-
tients from 24 centers in the United States and 
Canada who’d had an ultrasound-confirmed 
proximal DVT (in the popliteal or more 
proximal deep leg vein) within the previous 
14 days. Most patients received standard 
anti coagulation therapy to treat their DVT (5- 
10 days of heparin and 3-6 months of war-
farin). Patients were excluded if they had 
received thrombolytics, had arterial claudica-
tion, had a life expectancy of <6 months, were 
unable to put on ECS due to physical disabili-
ties or allergy, or were unable to participate in 
follow-up visits.
Patients were randomly assigned to 
wear active (30-40 mm Hg graduated) ECS or 
identical-looking placebo ECS with <5 mm Hg 
compression at the ankle for 2 years. Providers, 
study personnel and statisticians, and patients 
were all blinded to treatment allocation. Pa-
tients were asked to wear the stocking on the 
affected leg each day from when they woke 
until they went to bed.
Participants were followed at one, 6, 
12, 18, and 24 months. The primary outcome 
was the cumulative incidence of PTS diag-
nosed at 6 months or later using Ginsberg’s 
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criteria of ipsilateral pain and swelling of at 
least 1 month’s duration.8 Secondary out-
comes included severity of PTS, presence of 
leg ulcers, recurrence of venous thromboem-
bolism (VTE), death, adverse events, venous 
valvular reflux, and quality of life (QOL). 
Outcomes were measured objectively using 
a validated scale (the Villalta scale) for PTS 
severity and the 36-item Short Form Health 
Survey (SF-36) and the Venous Insufficiency 
Epidemiological and Economic Study Quality 
of Life (VEINES-QOL) questionnaire to mea-
sure QOL.9-11
There were 409 patients in the ECS group 
and 394 in the placebo group. Baseline char-
acteristics, including body mass index (BMI), 
VTE risk factors, and anticoagulation treat-
ment regimens, were similar between groups. 
The average age was 55.4 years in the study 
group (standard deviation [SD] ± 15.3 years) 
and 54.8 years (SD ± 15.8 years) in the place-
bo group. Men comprised 62.4% of the active 
group and 57.9% of the placebo group. Ap-
proximately 90% of the participants in both 
groups were white. 
At one month, approximately 95% of 
participants in both the active and placebo 
groups used the stockings; at 24 months, a 
little less than 70% of the participants in both 
groups continued to use the stockings. The 
percentage of people who used the stockings 
for at least 3 days a week was similar across 
both groups. 
The cumulative incidence of PTS during 
follow-up was 14.2% in the active group vs 
12.7% in the placebo group, with a hazard ratio 
of 1.13 (95% confidence interval [CI], .73-1.76; 
P=.58). There were no differences in any of the 
secondary outcomes. Prespecified subgroup 
analyses found that age, BMI, and severity of 
DVT had no effect on the outcomes. There was 
a marginal benefit for ECS for women (P=.047) 
over men, but this does not likely reflect a true 
difference because the CIs surrounding the 
hazard ratios for men and women overlapped 
and crossed the null value. 
WHAT’S NEW
New evidence contradicts  
previous studies
Two prior studies showed that using 30 to 
40 mm Hg ECS decreased the incidence of 
PTS after proximal DVT.6,7 However, these 
were smaller, open-label, single-center 
studies. This study by Kahn et al1 was the 
first placebo-controlled, randomized, mul-
ticenter study that used validated instru-
ments to measure PTS and QOL. It found 
no benefit in using ECS, thus contradicting 
the results of the prior studies.
There are currently no guidelines or con-
sensus statements for or against the use of 
ECS after DVT.
CAVEATS
High nonadherence rates  
might have affected the results
In both groups, adherence to the assigned in-
tervention diminished throughout the study. 
Overall, approximately 95% of patients re-
ported wearing their stockings at one month; 
this dropped to just under 70% by 2 years. 
Theoretically, this could have affected effi-
cacy outcomes. However, the decrease was 
similar in both groups and represents what is 
observed in clinical practice. A prespecified 
per protocol analysis of patients who wore 
their ECS more regularly found no benefit.
It is possible that a “placebo effect” 
could explain the lack of difference between 
groups. However, the placebo stockings 
provided virtually no compression, and the 
2-year cumulative incidence of PTS in both 
the treatment and placebo groups was simi-
lar to that seen in control groups in prior 
studies.6,7
Finally, the incidence of PTS in this study 
was much lower than the 25% to 50% inci-
dence reported in previous studies. Kahn et 
al1 suggested that this was because they used 
more stringent and standardized criteria for 
PTS than was used in previous research.
CHALLENGES TO IMPLEMENTATION
there are no barriers  
to ending this practice
We see no challenges to implementation of 
this recommendation.                 JFP
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